Feedback and Support
NEN-ID application was made possible through the support of many people. We would like to encourage users to contact us at nenid.contact [at] gmail.com
. Tracking usage in this fashion allows us (1) to justify the monetary expenses, (2) contact users if changes are made to the software and (3) try to connect with the community interested in neuroendocrine neoplasms. This is optional and not reauired for usage, and any information such as email adresses will be treated with utmost care and not be shared with third parties.
If you should need help in running this tool or have questions regarding the software, please use the email provided above or contact the authors @cgeisenberger and @whackeng.
Introduction
This web application uses bioinformatic and machine learning methods to analyze array-based DNA methylation data. It is specifically designed for Neuroendocrine Neoplasms (NENs). Among others, the software can determine the tissue of origin, infer tumor purity and generate a genomic copy-number profile. Details concerning the classification algorithm are outlined in the accompanying publication (Hackeng et al., Clinical Cancer Research, 2020 [manuscript provisionally accepted]).
Quick How To
Submit button
is activated after succesful file transferSubmit Button
to start processing of samplesTechnical Notes
Due to large demands in memory and computational power, uploads are currently limited to a maximum of ten cases. In case higher throughput is desired, users are suggested to either set up a local instance of the application or use the underlying R package directly. For more information, visit the github repositories of crystalmeth and methedrine. Contact the authors if help is required (see Section Support for more information).
Test Data
In case users would like to try the software, data and example reports for one test sample (450k) can be downloaded here (right click -> 'save link as').
Disclaimer
NetID is not an official diagnostic tool. Classification using methylation profiling is a research application under development, it is not verified and has not been clinically validated. Implementation of the results in a clinical setting is in the sole responsibility of the treating physician. Intended for non-commercial use only.